Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment
Nirschi et al., 2023
Exclusive content
If you are a customer with an existing My Lunaphore account